ArticleZeitschrift fur Gastroenterologie2025
Correction: From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis.
Elisabeth Schnoy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.